SARTORIUS STED BIO (EPA:DIM) | Finanzwire

Basculer en Français

11008	Companies
241201	Keywords
169756	Articles
129838	Press releases

Home
Companies
SARTORIUS STED BIO

PRESS RELEASE

published on 06/17/2025 at 16:00, 1 year 2 months ago

Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France
Sartorius Stedim Biotech expands manufacturing and R&D capacities for innovative bioprocess solutions in France, doubling cleanroom space, introducing automated production lines and logistics, enhancing lab facilities, and emphasizing sustainability

Innovation Expansion Sartorius Stedim Biotech France Bioprocess Solutions
BRIEF

published on 06/02/2025 at 11:14, 1 year 3 months ago

Sartorius Stedim Biotech: Declaration on Share Capital

Share Capital Sartorius Stedim Biotech AMF Regulations Shares And Voting Rights Aubagne
PRESS RELEASE

published on 06/02/2025 at 11:10, 1 year 3 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech S.A. in Aubagne, France declares total number of shares and voting rights as of May 31, 2025

Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE

published on 06/02/2025 at 11:09, 1 year 3 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital as per French regulatory requirements

Voting Rights Shares Sartorius Stedim Biotech Issued Capital French Regulatory
BRIEF

published on 05/05/2025 at 12:20, 1 year 4 months ago

Publication of the number of shares and voting rights of Sartorius Stedim Biotech

Share Capital Voting Rights Actions Sartorius Stedim Biotech Regulatory Information
PRESS RELEASE

published on 05/05/2025 at 12:15, 1 year 4 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA makes declaration on number of shares and voting rights in the issued capital, meeting regulatory requirements. Details in the announcement

Voting Rights Déclaration Shares Sartorius Stedim Biotech Regulatory Requirements
BRIEF

published on 04/16/2025 at 14:46, 1 year 5 months ago

Sartorius Stedim Biotech First Quarter 2025 Results

EBITDA Sartorius Stedim Biotech Turnover 2025 Forecast Bioproduction
BRIEF

published on 04/16/2025 at 07:05, 1 year 5 months ago

Sartorius Stedim Biotech Reports Q1 2025 Results with Strong Growth

Financial Performance Profitability Biotech Growth Q1 2025 Results Biomanufacturing Demand
PRESS RELEASE

published on 04/16/2025 at 07:00, 1 year 5 months ago

Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
Sartorius Stedim Biotech reports strong first quarter results for 2025 with 10.4% sales revenue growth and a full-year sales revenue guidance increase of 7%

Sartorius Stedim Biotech Biopharmaceutical Industry First Quarter Results Full-year Guidance Sales Revenue Growth
BRIEF

published on 04/01/2025 at 10:36, 1 year 5 months ago

Sartorius Stedim Biotech Announces Share and Voting Rights Details

Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital

Accesswire

Published on 09/16/2026 at 23:45, 10 hours 1 minute ago

Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 12 hours 16 minutes ago

Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 16 hours 51 minutes ago

CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 18 hours 46 minutes ago

2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 19 hours 46 minutes ago

Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/17/2026 at 09:30, 16 minutes ago

Allane Mobility Group and DEKRA expand their network of return locations
Published on 09/17/2026 at 09:28, 18 minutes ago

KNDS THL20 TURRETS SELECTED FOR INDIA’S NEW LIGHT COMBAT HELICOPTER PROGRAM
Published on 09/17/2026 at 09:00, 46 minutes ago

Encavis completes EUR 282 million non-recourse project financing for 351 MW solar PV portfolio in Italy
Published on 09/17/2026 at 09:00, 46 minutes ago

Removal - UDI STEERS Notes Series 2007-1
Published on 09/17/2026 at 09:00, 46 minutes ago

Grünenthal announces pricing of €850 million of bonds

Les Echos

Published on 09/16/2026 at 20:46, 13 hours ago

LNA SANTE : 2026 First Half Results
Published on 09/16/2026 at 17:45, 16 hours 1 minute ago

5th edition of “On the way up” show
Published on 09/16/2026 at 17:45, 16 hours 1 minute ago

Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 2 hours ago

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 15 hours ago

Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE